The signaling responsiveness of p-STAT5 to IL-7 stimulation was tested in CD4+ and CD8+ T cells; while all healthy donors (19/19) responded to IL-7, only 6/19 breast cancer patients responded to cytokine stimulation. This evidence concerns the gene CD4 and breast carcinoma.